Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Staruschenko

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
JCI Insight|April 5, 2022
Effects of elevation of ANP and its deficiency on cardiorenal functionDaria V Ilatovskaya, Vladislav Levchenko, Kristen Winsor, et al.
Iscience|August 30, 2022
Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat modelLashodya V Dissanayake, Adrian Zietara, Vladislav Levchenko, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Loss of Chloride Channel 6 (CLC-6) Affects Vascular Smooth Muscle Contractility and Arterial Stiffness via Alterations to Golgi Calcium StoresChristine A Klemens, Evgeny G Chulkov, Jing Wu, et al.
Physiological Genomics|April 19, 2021
Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN ratsDenisha R Spires, Oleg Palygin, Vladislav Levchenko, et al.
American Journal of Physiology. Cell Physiology|September 2, 2025
The Role of Carnitine Palmitoyl Transferase 2 in the Progression of Salt-Sensitive HypertensionLashodya V Dissanayake, Brody A Smith, Adrian Zietara, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2013
Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertensionTengis S Pavlov, Vladislav Levchenko, Paul M O'Connor, et al.
Circulation|September 28, 2020
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart AssociationJanani Rangaswami, Vivek Bhalla, Ian H de Boer, et al.
American Journal of Physiology. Renal Physiology|October 1, 2019
Progression of diabetic kidney disease in T2DN ratsOleg Palygin, Denisha Spires, Vladislav Levchenko, et al.
Clinical Science (London, England : 1979)|April 9, 2014
Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibitionMd Abdul Hye Khan, Tengis S Pavlov, Sarah V Christain, et al.
American Journal of Physiology. Renal Physiology|April 14, 2017
Intravital imaging of the kidney in a rat model of salt-sensitive hypertensionBradley T Endres, Ruben M Sandoval, George J Rhodes, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
JCI Insight|April 5, 2022
Effects of elevation of ANP and its deficiency on cardiorenal functionDaria V Ilatovskaya, Vladislav Levchenko, Kristen Winsor, et al.
Iscience|August 30, 2022
Lack of xanthine dehydrogenase leads to a remarkable renal decline in a novel hypouricemic rat modelLashodya V Dissanayake, Adrian Zietara, Vladislav Levchenko, et al.
Hypertension (Dallas, Tex. : 1979)|January 4, 2021
Loss of Chloride Channel 6 (CLC-6) Affects Vascular Smooth Muscle Contractility and Arterial Stiffness via Alterations to Golgi Calcium StoresChristine A Klemens, Evgeny G Chulkov, Jing Wu, et al.
Physiological Genomics|April 19, 2021
Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN ratsDenisha R Spires, Oleg Palygin, Vladislav Levchenko, et al.
American Journal of Physiology. Cell Physiology|September 2, 2025
The Role of Carnitine Palmitoyl Transferase 2 in the Progression of Salt-Sensitive HypertensionLashodya V Dissanayake, Brody A Smith, Adrian Zietara, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2013
Deficiency of renal cortical EGF increases ENaC activity and contributes to salt-sensitive hypertensionTengis S Pavlov, Vladislav Levchenko, Paul M O'Connor, et al.
Circulation|September 28, 2020
Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease: A Scientific Statement From the American Heart AssociationJanani Rangaswami, Vivek Bhalla, Ian H de Boer, et al.
American Journal of Physiology. Renal Physiology|October 1, 2019
Progression of diabetic kidney disease in T2DN ratsOleg Palygin, Denisha Spires, Vladislav Levchenko, et al.
Clinical Science (London, England : 1979)|April 9, 2014
Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibitionMd Abdul Hye Khan, Tengis S Pavlov, Sarah V Christain, et al.
American Journal of Physiology. Renal Physiology|April 14, 2017
Intravital imaging of the kidney in a rat model of salt-sensitive hypertensionBradley T Endres, Ruben M Sandoval, George J Rhodes, et al.
Pageof 20